|
CCAR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.93980395582594E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.43980000436528E-08 |
| Normal-vs-Stage2 |
2.57879999576716E-08 |
| Normal-vs-Stage3 |
2.54170018365585E-11 |
| Normal-vs-Stage4 |
2.67750044358195E-10 |
| Stage1-vs-Stage2 |
1.157610E-01 |
| Stage1-vs-Stage3 |
2.842100E-03 |
| Stage1-vs-Stage4 |
4.662200E-03 |
| Stage2-vs-Stage3 |
5.210800E-01 |
| Stage2-vs-Stage4 |
4.303600E-01 |
| Stage3-vs-Stage4 |
8.767200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06370023900126E-10 |
| Normal-vs-AfricanAmerican |
8.18150000000406E-05 |
| Normal-vs-Asian |
4.13230000000375E-05 |
| Caucasian-vs-AfricanAmerican |
9.098400E-01 |
| Caucasian-vs-Asian |
3.428000E-01 |
| AfricanAmerican-vs-Asian |
4.781800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76240000371308E-09 |
| Normal-vs-Female |
1.54219970127656E-10 |
| Male-vs-Female |
8.375800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31340000045321E-07 |
| Normal-vs-Age(41-60Yrs) |
1.47900025559977E-10 |
| Normal-vs-Age(61-80Yrs) |
1.78430048514144E-10 |
| Normal-vs-Age(81-100Yrs) |
3.837700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.464300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.024700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.712170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.988000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.261800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.716600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.790200E-04 |
| Classical-VS-Follicular |
3.889800E-01 |
| Classical-VS-Other |
7.955200E-01 |
| Classical-VS-Normal |
4.37900005145764E-09 |
| Tall-VS-Follicular |
2.471700E-02 |
| Tall-VS-Other |
6.077600E-02 |
| Tall-VS-Normal |
1.82350023969491E-10 |
| Follicular-VS-Other |
6.278400E-01 |
| Follicular-VS-Normal |
6.64889999946183E-07 |
| Other-VS-Normal |
6.021600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.01550015460828E-10 |
| Normal-vs-N1 |
4.38550000000371E-05 |
| N0-vs-N1 |
2.009800E-01 |
|
|
